Reader View AI Reader View Cantor Fitzgerald reiterates Lexeo Therapeutics stock Overweight rating www.investing.com · November 12, 2026 · 17:22 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link